Erratum: Tim-3 expression in cervical cancer promotes tumor metastasis (PLoS ONE (2013) 8: 1 (e53834) DOI: 10.1371/journal.pone.0053834);Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cao, Yang ^a   Zhou, Xiaoxi ^a   Huang, Xiaoyuan ^a   Li, Qinlu ^a   Gao, Lili ^a   Jiang, Lijun ^a   Huang, Mei ^a   Zhou, Jianfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN TIM 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CELL INVASION; CELL STRAIN SIHA; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HELA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MAJOR CLINICAL STUDY; METASTASIS; METASTASIS POTENTIAL; MIGRATION INHIBITION; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING;

ANIMALIA;

EID: 84872404413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152830     Document Type: Erratum

References (19)

1. Anderson AC, (2012) Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 24: 213-216.
2. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK, (2011) Emerging Tim-3 functions in antimicrobial and tumor immunity. Cell 32(8): 345-349.
3. Norde WJ, Hobo W, van der Voort R, Dolstra H, (2012) Co-inhibitory molecules in hematological malignancies: targets for therapeutic intervention. Blood 120(4): 728-736.
4. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, et al. (2010) Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 207: 2187-2194.
5. Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, et al. (2011) Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117: 4501-4510.
6. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, et al. (2010) Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 207: 2175-2186.
7. Huang XY, Bai XY, Cao Y, Wu JY, Huang M, et al. (2010) Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion. J Exp Med 207: 505-520.
8. No JH, Kim MK, Jeon YT, Kim YB, Song YS, (2011) Human papillomavirus vaccine: widening the scope for cancer prevention. Mol Carcinog 50: 244-253.
9. Ibrahim R, Frederickson H, Parr A, Ward Y, Moncur J, et al. (2006) Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism. Cancer 106(5): 1065-1077.
10. Kloth JN, Gorter A, Fleuren GJ, Oosting J, Uljee S, et al. (2008) Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J Pathol 215: 222-230.
11. Jan M, Chao MP, Cha AC, Alizadeh AA, Gentles AJ, et al. (2011) Prospective separation of normal and leukemic stem cells based on differential expression of Tim-3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci 108: 5009-5014.
12. Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, et al. (2010) Tim-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell 7: 708-717.
13. Geng H, Zhang GM, Li D, Zhang H, Yuan Y, et al. (2006) Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol 176: 1411-1420.
14. Zhou JF, Gao QL, Chen G, Huang XY, Lu YP, et al. (2005) Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability. Clin Cancer Res 11: 8431-8440.
15. Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, et al. (2006) Tim-3 is expressed in melanoma cells and is upregulated in TGF-Beta stimulated mast cells. J Invest Dermatol 127: 906-914.
16. Alderton GK, (2012) Stat3 promotes premetastatic niche formation. Nat Rev Cancer 12(7): 453.
17. Li S, Wang N, Brodt P, (2012) Metastatic cells can escape the proapoptotic effects of TNF-α through increased autocrine IL-6/stat3 signaling. Cancer Res 729(4): 865-875.
18. Kong LY, Alexander G, Wei J, Chantal RO, Wang YT, et al. (2010) Inhibition of p-Stat3 enhances IFN-α efficacy against metastatic melanoma in a murine model. Clin Cancer Res 16(9): 2550-2560.
19. Tu B, Du L, Fan QM, Tang Z, Tang TT, (2012) STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett 325(1): 80-88.